UroGen Pharma
URGN
URGN
105 hedge funds and large institutions have $328M invested in UroGen Pharma in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% more funds holding
Funds holding: 101 → 105 (+4)
2% more call options, than puts
Call options by funds: $344K | Put options by funds: $336K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
105
Holding in Top 10
1
Calls
$344K
Puts
$336K
Top Buyers
| 1 | +$24M | |
| 2 | +$13M | |
| 3 | +$12M | |
| 4 |
BlackRock
New York
|
+$7.82M |
| 5 |
Millennium Management
New York
|
+$2.26M |
Top Sellers
| 1 | -$5.21M | |
| 2 | -$3.11M | |
| 3 | -$2.39M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.95M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.95M |